Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

10
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (10)

Searched Name

Katy Van Kirk

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Wang Y, Yang W, Finlay HJ, Harikrishnan LS, Jiang J, Kamau MG, Van Kirk K, Nirschl DS, Taylor DS, Chen AYA, Yin X, Sleph PG, Yang RZ, Huang CS, Adam LP, Lawrence RM, Wexler RR, Salvati ME. Diphenylpyridylethanamine (DPPE)-based aminoheterocycles as cholesteryl ester transfer protein inhibitors. Bioorg Med Chem Lett 2014;24:860-4. [PMID: 24424134 DOI: 10.1016/j.bmcl.2013.12.088] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2013] [Revised: 12/18/2013] [Accepted: 12/19/2013] [Indexed: 11/26/2022]

Affiliation(s)

Yufeng Wang Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA.
Wu Yang Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Heather J Finlay Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Lalgudi S Harikrishnan Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Ji Jiang Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Muthoni G Kamau Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Katy Van Kirk Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
David S Nirschl Synthesis & Analysis Technology Team, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
David S Taylor Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Alice Ye A Chen Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Xiaohong Yin Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Paul G Sleph Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Richard Z Yang Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Christine S Huang Department of Preclinical Candidate Optimization, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Leonard P Adam Department of Biology, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
R Michael Lawrence Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Ruth R Wexler Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA
Mark E Salvati Department of Chemistry, Bristol-Myers Squibb, PO Box 4000, Princeton, NJ 08543-4000, USA

Collapse

Gardner DS, Santella JB, Duncia JV, Carter PH, Dhar T, Wu H, Guo W, Cavallaro C, Van Kirk K, Yarde M, Briceno SW, Robert Grafstrom R, Liu R, Patel SR, Tebben AJ, Camac D, Khan J, Watson A, Yang G, Rose A, Foster WR, Cvijic ME, Davies P, Hynes J. The discovery of BMS-457, a potent and selective CCR1 antagonist. Bioorg Med Chem Lett 2013;23:3833-40. [DOI: 10.1016/j.bmcl.2013.04.079] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2013] [Revised: 04/24/2013] [Accepted: 04/29/2013] [Indexed: 02/07/2023]

Cavallaro CL, Briceno S, Chen J, Cvijic ME, Davies P, Hynes J, Liu RQ, Mandlekar S, Rose AV, Tebben AJ, Van Kirk K, Watson A, Wu H, Yang G, Carter PH. Discovery and Lead Optimization of a Novel Series of CC Chemokine Receptor 1 (CCR1)-Selective Piperidine Antagonists via Parallel Synthesis. J Med Chem 2012;55:9643-53. [DOI: 10.1021/jm300896d] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]

Affiliation(s)

Cullen L. Cavallaro Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Stephanie Briceno Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Jing Chen Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Mary Ellen Cvijic Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Paul Davies Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
John Hynes Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Rui-Qin Liu Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Sandhya Mandlekar Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Anne V. Rose Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Andrew J. Tebben Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Katy Van Kirk Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Andrew Watson Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Hong Wu Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Guchen Yang Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States
Percy H. Carter Research and Development, Bristol-Myers Squibb Company, Route 206 and Provinceline Road, Princeton, New Jersey 08540, United States

Collapse

Harikrishnan LS, Finlay HJ, Qiao JX, Kamau MG, Jiang J, Wang TC, Li J, Cooper CB, Poss MA, Adam LP, Taylor DS, Chen AYA, Yin X, Sleph PG, Yang RZ, Sitkoff DF, Galella MA, Nirschl DS, Van Kirk K, Miller AV, Huang CS, Chang M, Chen XQ, Salvati ME, Wexler RR, Lawrence RM. Diphenylpyridylethanamine (DPPE) Derivatives as Cholesteryl Ester Transfer Protein (CETP) Inhibitors. J Med Chem 2012;55:6162-75. [DOI: 10.1021/jm300611v] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Affiliation(s)

Lalgudi S. Harikrishnan Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Heather J. Finlay Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Jennifer X. Qiao Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Muthoni G. Kamau Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Ji Jiang Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Tammy C. Wang Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
James Li Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Christopher B. Cooper Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Michael A. Poss Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Leonard P. Adam Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
David S. Taylor Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Alice Ye A. Chen Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Xiaohong Yin Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Paul G. Sleph Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Richard Z. Yang Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Doree F. Sitkoff Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Michael A. Galella Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
David S. Nirschl Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Katy Van Kirk Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Arthur V. Miller Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Christine S. Huang Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Ming Chang Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Xue-Qing Chen Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Mark E. Salvati Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
Ruth R. Wexler Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States
R. Michael Lawrence Department of Chemistry, ‡Department of Biology, §Department of Computer Aided Drug Design, ∥Department of Materials Science, ⊥Synthesis and Analysis Technology Team, #Department of Preclinical Candidate Optimization, and ∞Department of Pharmaceutics, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, New Jersey 08543-4000, United States

Collapse

Watterson SH, Langevine CM, Van Kirk K, Kempson J, Guo J, Spergel SH, Das J, Moquin RV, Dyckman AJ, Nirschl D, Gregor K, Pattoli MA, Yang X, McIntyre KW, Yang G, Galella MA, Booth-Lute H, Chen L, Yang Z, Wang-Iverson D, McKinnon M, Dodd JH, Barrish JC, Burke JR, Pitts WJ. Novel tricyclic inhibitors of IKK2: Discovery and SAR leading to the identification of 2-methoxy-N-((6-(1-methyl-4-(methylamino)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-7-yl)pyridin-2-yl)methyl)acetamide (BMS-066). Bioorg Med Chem Lett 2011;21:7006-12. [DOI: 10.1016/j.bmcl.2011.09.111] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2011] [Revised: 09/23/2011] [Accepted: 09/27/2011] [Indexed: 02/02/2023]

Kempson J, Spergel SH, Guo J, Quesnelle C, Gill P, Belanger D, Dyckman AJ, Li T, Watterson SH, Langevine CM, Das J, Moquin RV, Furch JA, Marinier A, Dodier M, Martel A, Nirschl D, Van Kirk K, Burke JR, Pattoli MA, Gillooly K, McIntyre KW, Chen L, Yang Z, Marathe PH, Wang-Iverson D, Dodd JH, McKinnon M, Barrish JC, Pitts WJ. Novel tricyclic inhibitors of IkappaB kinase. J Med Chem 2009;52:1994-2005. [PMID: 19267461 DOI: 10.1021/jm8015816] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]

Roberge JY, Harikrishnan LS, Kamau MG, Ruan Z, Van Kirk K, Liu Y, Cooper CB, Poss MA, Dickson JK, Gavai AV, Chao ST, Leith LW, Bednarz MS, Mathur A, Kakarla R, Schnur DM, Vaz R, Lawrence RM. Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linker. ACTA ACUST UNITED AC 2009;11:72-82. [PMID: 19086798 DOI: 10.1021/cc800051u] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]

Yang W, Ruan Z, Wang Y, Van Kirk K, Ma Z, Arey BJ, Cooper CB, Seethala R, Feyen JHM, Dickson JK. Discovery and Structure−Activity Relationships of Trisubstituted Pyrimidines/Pyridines as Novel Calcium-Sensing Receptor Antagonists. J Med Chem 2009;52:1204-8. [DOI: 10.1021/jm801178c] [Citation(s) in RCA: 47] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]

Affiliation(s)

Wu Yang Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Zheming Ruan Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Yufeng Wang Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Katy Van Kirk Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Zhengping Ma Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Brian J. Arey Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Christopher B. Cooper Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Ramakrishna Seethala Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
Jean H. M. Feyen Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400
John K. Dickson Discovery Chemistry, Early Discovery Chemistry, and Metabolic and Cardiovascular Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, Princeton, New Jersey 08543-5400

Collapse

Wang H, Ruan Z, Li JJ, Simpkins LM, Smirk RA, Wu SC, Hutchins RD, Nirschl DS, Van Kirk K, Cooper CB, Sutton JC, Ma Z, Golla R, Seethala R, Salyan MEK, Nayeem A, Krystek SR, Sheriff S, Camac DM, Morin PE, Carpenter B, Robl JA, Zahler R, Gordon DA, Hamann LG. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1. Bioorg Med Chem Lett 2008;18:3168-72. [PMID: 18485702 DOI: 10.1016/j.bmcl.2008.04.069] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2008] [Revised: 04/18/2008] [Accepted: 04/28/2008] [Indexed: 11/29/2022]

Dodd DS, Martinez RL, Kamau M, Ruan Z, Van Kirk K, Cooper CB, Hermsmeier MA, Traeger SC, Poss MA. Solid-Phase Synthesis of 5-Substituted Amino Pyrazoles. ACTA ACUST UNITED AC 2005;7:584-8. [PMID: 16004502 DOI: 10.1021/cc049814s] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]